Vidal-Ribas, Pablo http://orcid.org/0000-0002-4863-9247
Govender, Theemeshni
Sundaram, Rajeshwari
Perlis, Roy H.
Gilman, Stephen E. http://orcid.org/0000-0002-8331-6419
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Article History
Received: 4 August 2021
Revised: 7 December 2021
Accepted: 20 December 2021
First Online: 10 January 2022
Conflict of interest
: Dr. Perlis holds equity in Psy Therapeutics and Belle.ai. He receives consulting fees as a scientific advisor to Burrage Capital, Genomind, RID Ventures, Takeda, and Belle.ai. The other authors declare no conflict of interest.